GlassScriptPhysician profile
Mallory Irene Chiang
NPI 1174387773
$4,610.23
in general payments reported to CMS, 2019-2025
11 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $3,233 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,116 · Travel and Lodging: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,115.95 |
| Travel and Lodging | $1,494.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,436.45 | 2024-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Curonix LLC | $490.74 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $248.97 | 2024 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $147.97 | 2024-2025 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.80 | 2024-2025 | Relistor |
| Abbvie INC. | $75.68 | 2025 | |
| Forte Bio-Pharma LLC | $39.06 | 2024 | Prolate, Nalocet |
| Mml US, INC. | $35.16 | 2025 | Reactiv8 |
| Spr Therapeutics, INC | $23.70 | 2024 | Sprint Pns System |
| Fidia Pharma USA INC. | $15.39 | 2025 | Hymovis, Triluron |
| Ibsa Pharma INC. | $13.31 | 2024 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mallory Chiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.